Eric Laub | Vice President of Investor Relations |
Richard Murray | President & Chief Executive Officer |
Beth Trehu | Chief Medical Officer |
Kim Drapkin | Chief Financial Officer |
Dmitri Wiederschain | Chief Scientific Officer |
Ted Tenthoff | Piper Sandler |
Boris Peaker | Cowen |
Gavin Scott | JPMorgan |
Ryan Deschner | Raymond James |
Colleen Kusy | Baird |
Nick Abbott | Wells Fargo |
Zegbeh Jallah | ROTH Capital Partners |
Swayampakula Ramakanth | H.C. Wainwright |
Good morning, ladies and gentlemen and welcome to the Jounce Therapeutics Fourth Quarter and Full Year 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference is being recorded at the company's request. I will now turn the call over to your host, Eric Laub, with Jounce Therapeutics.